1. Home
  2. AMP vs EW Comparison

AMP vs EW Comparison

Compare AMP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMP
  • EW
  • Stock Information
  • Founded
  • AMP 1894
  • EW 1958
  • Country
  • AMP United States
  • EW United States
  • Employees
  • AMP N/A
  • EW N/A
  • Industry
  • AMP Investment Managers
  • EW Industrial Specialties
  • Sector
  • AMP Finance
  • EW Health Care
  • Exchange
  • AMP Nasdaq
  • EW Nasdaq
  • Market Cap
  • AMP 44.9B
  • EW 40.7B
  • IPO Year
  • AMP 2005
  • EW 2000
  • Fundamental
  • Price
  • AMP $492.27
  • EW $73.68
  • Analyst Decision
  • AMP Hold
  • EW Buy
  • Analyst Count
  • AMP 6
  • EW 20
  • Target Price
  • AMP $514.60
  • EW $79.45
  • AVG Volume (30 Days)
  • AMP 458.9K
  • EW 4.3M
  • Earning Date
  • AMP 04-24-2025
  • EW 04-23-2025
  • Dividend Yield
  • AMP 1.30%
  • EW N/A
  • EPS Growth
  • AMP 0.13
  • EW 201.77
  • EPS
  • AMP 29.43
  • EW 7.02
  • Revenue
  • AMP $18,082,000,000.00
  • EW $5,522,300,000.00
  • Revenue This Year
  • AMP N/A
  • EW $10.07
  • Revenue Next Year
  • AMP $4.44
  • EW $9.65
  • P/E Ratio
  • AMP $16.71
  • EW $10.54
  • Revenue Growth
  • AMP 9.09
  • EW N/A
  • 52 Week Low
  • AMP $385.74
  • EW $58.93
  • 52 Week High
  • AMP $582.05
  • EW $95.25
  • Technical
  • Relative Strength Index (RSI)
  • AMP 57.81
  • EW 52.18
  • Support Level
  • AMP $471.76
  • EW $74.25
  • Resistance Level
  • AMP $485.90
  • EW $76.13
  • Average True Range (ATR)
  • AMP 12.60
  • EW 1.75
  • MACD
  • AMP 3.66
  • EW -0.02
  • Stochastic Oscillator
  • AMP 94.03
  • EW 56.51

About AMP Ameriprise Financial Inc.

Ameriprise Financial is a major player in the US market for asset and wealth management, with around $1.5 trillion in total assets under management and administration at the end of 2024. With about 10,500 advisors, Ameriprise has one of the largest branded advisor networks in the industry. About 80% of the company's revenue comes from its asset and wealth management segments. Ameriprise has reduced its exposure to insurance with the sale of its auto and home insurance business in 2019 and discontinuing the sale of proprietary fixed annuities in 2020.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: